BridgeMD
Compares treatment options for Mesenteric Ischemia
Official title Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia
ClinicalTrials.gov ID: NCT05244629
What this study is testing
- What it's testing
- Chronic mesenteric ischemia (CMI) is often caused by narrowings in the arteries providing blood to the intestines. Endovascular stent placement is considered the preferred treatment for this condition.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with symptomatic CMI of atherosclerotic or atherothrombotic etiology
- Intended endovascular treatment
- Symptoms consistent with CMI (pain, weight loss, diarrhea)
- Significant ostial stenosis (\>50%) of the superior mesenteric artery on CTA
- Significant stenosis on angiography (\>50% or \>15mmHg pressure gradient)
You likely can't join if
- No informed consent
- Non atherosclerotic cause of MI
- Acute mesenteric ischemia (AMI)
- Signs of acute bowel ischemia, peritonitis, laparotomy, sepsis
- Previous stent treatment in the superior mesenteric artery(ies)
- Target artery lesions \>4cm in length
See the full eligibility criteria
- Patients with symptomatic CMI of atherosclerotic or atherothrombotic etiology
- Intended endovascular treatment
- Symptoms consistent with CMI (pain, weight loss, diarrhea)
- Significant ostial stenosis (\>50%) of the superior mesenteric artery on CTA
- Significant stenosis on angiography (\>50% or \>15mmHg pressure gradient)
- Patients \> 18 years
- No informed consent
- Non atherosclerotic cause of MI
- Acute mesenteric ischemia (AMI)
- Signs of acute bowel ischemia, peritonitis, laparotomy, sepsis
- Previous stent treatment in the superior mesenteric artery(ies)
- Target artery lesions \>4cm in length
- Unable to cross lesion with guidewire
- Non-significant stenosis angiographically
- Pregnancy
- Allergies to contrast media or stent materials
The study team makes the final eligibility decision.
Where it's taking place
- København Ø, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include København Ø, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.